MENU
+Compare
STXS
Stock ticker: ASE
AS OF
Dec 18, 03:23 PM (EDT)
Price
$2.38
Change
+$0.01 (+0.42%)
Capitalization
214.36M

STXS Stereotaxis Forecast, Technical & Fundamental Analysis

a designer of robotic cardiology instrument navigation systems

STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for STXS with price predictions
Dec 17, 2024

STXS's RSI Oscillator recovers from overbought zone

The 10-day RSI Indicator for STXS moved out of overbought territory on December 03, 2024. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 instances where the indicator moved out of the overbought zone. In of the 35 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STXS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

STXS broke above its upper Bollinger Band on November 12, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 64 cases where STXS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 17, 2024. You may want to consider a long position or call options on STXS as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for STXS just turned positive on December 16, 2024. Looking at past instances where STXS's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

STXS moved above its 50-day moving average on November 12, 2024 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for STXS crossed bullishly above the 50-day moving average on November 15, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where STXS advanced for three days, in of 229 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 186 cases where STXS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. STXS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.970) is normal, around the industry mean (23.300). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (7.776) is also within normal values, averaging (43.338).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STXS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

STXS is expected to report earnings to fall 25.00% to -5 cents per share on March 18

Stereotaxis STXS Stock Earnings Reports
Q4'24
Est.
$-0.06
Q3'24
Missed
by $0.03
Q2'24
Missed
by $0.02
Q1'24
Est.
$-0.06
Q4'23
Est.
$-0.07
The last earnings report on November 11 showed earnings per share of -7 cents, missing the estimate of -5 cents. With 81.43K shares outstanding, the current market capitalization sits at 214.36M.
A.I. Advisor
published General Information

General Information

a designer of robotic cardiology instrument navigation systems

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
710 North Tucker Boulevard
Phone
+1 314 678-6100
Employees
122
Web
https://www.stereotaxis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGTDX64.71-0.25
-0.38%
Putnam Global Technology C
MSIBX16.28-0.10
-0.61%
Morgan Stanley Inst Passport ovrs eq A
CSIAX9.22-0.06
-0.65%
Centerstone International A
HILAX18.32-0.14
-0.76%
Hartford International Value A
FLXSX16.89-0.20
-1.17%
Fidelity Flex Small Cap Index

STXS and Stocks

Correlation & Price change

A.I.dvisor tells us that STXS and ZIMV have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that STXS and ZIMV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STXS
1D Price
Change %
STXS100%
-2.07%
ZIMV - STXS
33%
Poorly correlated
+1.60%
QTRX - STXS
27%
Poorly correlated
-2.63%
CVRX - STXS
27%
Poorly correlated
-1.64%
ISPC - STXS
26%
Poorly correlated
+1.53%
RPID - STXS
26%
Poorly correlated
+6.00%
More